Clinical Trial-Algae and Cholesterol Absorption-Cholesterol

The primary objective of this study is to investigate the effects of wakame and spirulina consumption on intestinal cholesterol absorption.

Study Type  : Interventional  (Clinical Trial)
Estimated Enrollment  : 37 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Prevention
Official Title: Effects of Wakame and Spirulina Consumption on Intestinal Cholesterol Absorption in Non- Hypercholesterolemic Men and Women
Actual Study Start Date  : October 24, 2017
Estimated Primary Completion Date  : September 2018
Estimated Study Completion Date  : September 2018
Contacts
Contact: José van den Driessche, MSc +31 43 388 1313 j.vandendriessche@maastrichtuniversity.nl
Locations
Netherlands
Maastricht University Medical Center Recruiting
Maastricht, Limburg, Netherlands, 6229ER
Contact: José van den Driessche, MSc    +31 43 3881313    j.vandendriessche@maastrichtuniversity.nl

 

ClinicalTrials.gov Identifier: NCT03380611
* The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.